InvestSMART

Invex Therapeutics Ltd (ASX: IXC) - Announcements

- Current share price for IXC : $0.105

ASX company news and announcements for Invex Therapeutics Ltd (IXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invex Therapeutics Ltd (IXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invex Therapeutics Ltd (IXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invex Therapeutics Ltd (IXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Exclusive Collaboration and Manufacturing Agreement 27 Sep 2021 9:58AM $0.680 $0.105 fallen by 84.56%
$8 Trading Halt 24 Sep 2021 9:15AM $0.680 $0.105 fallen by 84.56%
$8 Corporate Governance Statement 27 Aug 2021 9:41AM $0.740 $0.105 fallen by 85.81%
$8 Appendix 4G 27 Aug 2021 9:40AM $0.740 $0.105 fallen by 85.81%
$8 Appendix 4E and Annual Report 27 Aug 2021 8:03AM $0.740 $0.105 fallen by 85.81%
$8 Invex Granted Key European Patent for Exenatide 16 Aug 2021 11:20AM $0.610 $0.105 fallen by 82.79%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 23 Jul 2021 12:43PM $0.610 $0.105 fallen by 82.79%
$8 Appendix 2A 5 Jul 2021 8:22AM $0.630 $0.105 fallen by 83.33%
$8 Notice of Upcoming Release of Securities from Escrow 23 Jun 2021 1:49PM $0.600 $0.105 fallen by 82.50%
$8 Investor Presentation 21 Jun 2021 11:36AM $0.590 $0.105 fallen by 82.20%
$8 Invex Receives Written Response from FDA on Type C Meeting 15 Jun 2021 8:31AM $0.545 $0.105 fallen by 80.73%
$8 Formulation and Manufacturing Update 7 May 2021 8:41AM $0.690 $0.105 fallen by 84.78%
$8 Invex Granted Type C Meeting with FDA 22 Apr 2021 9:29AM $0.755 $0.105 fallen by 86.09%
$8 Appendix 4C - quarterly 13 Apr 2021 9:15AM $0.755 $0.105 fallen by 86.09%
$8 Appendix 3G 9 Apr 2021 4:56PM $0.770 $0.105 fallen by 86.36%
$8 Change of Director's Interest Notice 9 Apr 2021 4:55PM $0.770 $0.105 fallen by 86.36%
$8 Results of Meeting 8 Apr 2021 6:34PM $0.775 $0.105 fallen by 86.45%
$8 Chairman's Address to Shareholders 8 Apr 2021 5:56PM $0.775 $0.105 fallen by 86.45%
$8 Invex Files Pre-IND/Type B Meeting Request with US FDA 31 Mar 2021 8:52AM $0.785 $0.105 fallen by 86.62%
$8 Investor Presentation 18 Mar 2021 8:59AM $0.795 $0.105 fallen by 86.79%
$8 Invex to Present at Upcoming Small Caps Conference 15 Mar 2021 10:47AM $0.840 $0.105 fallen by 87.50%
$8 Postcard to Shareholders 8 Mar 2021 9:15AM $0.765 $0.105 fallen by 86.27%
$8 Notice of General Meeting/Proxy Form 8 Mar 2021 9:12AM $0.765 $0.105 fallen by 86.27%
$8 US Trademark Granted for Presendin 26 Feb 2021 8:50AM $0.850 $0.105 fallen by 87.65%
$8 Initial Director's Interest Notice 16 Feb 2021 1:11PM $0.950 $0.105 fallen by 88.95%

176 - 200 of 301 results

Page 8 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.